Healthcare analytics compliance company Protenus raised $17 million in new funding, its leadership announced this week. The Series C round was…
Super UserAugust 26, 2019
REGISTER NOW FOR OUR GREATLY ANTICIPATED 4TH ANNUAL REGIONAL CONFERENCE SEPTEMBER 19, 2019 Inova Center for Personalized Health, Fairfax You’re…
Super UserAugust 26, 2019
With an FDA approval for its pricey CAR-T therapy Yescarta under its belt and more treatments in the pipeline, Gilead’s…
Super UserAugust 26, 2019
REGENXBIO Inc. (RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on…
Super UserAugust 26, 2019
Shipping containers are continuing to prove their worth outside of transportation. From serving as a community-connecting space to an urban…
Super UserAugust 26, 2019
Bob Kramer joins BioTalk to discuss his history with Emergent, his vision for the company, and Emergent’s commitment to the…
Super UserAugust 19, 2019
George Washington University just sold a portion of its royalty rights for a drug developed in its school of medicine,…
Super UserAugust 19, 2019
Through gene analysis, researchers have found different types of interferons in systemic lupus erythematosus (SLE) tissues and cells, such as…
Super UserAugust 19, 2019
Targeting Metabesity 2019, co-chaired by Kinexum Executive Chairman Zan Fleming and Stanford Professor Larry Steinman (a co-discoverer of Tysabri), will…
Super UserAugust 19, 2019